BPC-157 is not licensed by the MHRA for human or veterinary use in the United Kingdom
But with a 2mg/mL concentration (5mL of water added), that same 4mg dose requires 2.0mL of liquid, which is an entire insulin syringe worth and creates a large, uncomfortable injection volume
It is important to note that this depletion is unlikely to be attributed to colitis-associated nutrient absorption defects, as B 12 is typically absorbed in the terminal ileum 26 , while DSS primarily affects the distal colon 61
Oral administration is supported by research showing BPC-157's gastric stability and absorption, making it viable for gastrointestinal conditions or patients uncomfortable with injections
The trend establishes this medicine as a preferred choice for hospital and clinic use
Throughout this period, the favorable safety profile remained consistent with no delayed-onset adverse effects or concerning laboratory changes emerging over time